JBC

HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


This Article
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Lai, T. S.
Right arrow Articles by Greenberg, G. S.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Lai, T. S.
Right arrow Articles by Greenberg, G. S.
Social Bookmarking
 Add to CiteULike   Add to Complore   Add to Connotea   Add to Del.icio.us   Add to Digg   Add to Reddit   Add to Technorati  
What's this?

J. Biol. Chem., Vol. 269, Issue 40, 24596-24601, 10, 1994

Carboxyl-terminal truncation of recombinant factor XIII A-chains. Characterization of minimum structural requirement for transglutaminase activity

TS Lai, KE Achyuthan, MA Santiago and GS Greenberg
Department of Medicine, Duke University Medical Center, Durham, North Carolina 27710.

A series of truncation mutants lacking 218, 229, 250, and 269 amino acid residues from the carboxyl terminus of blood coagulation factor XIII A-chains (FXIII A), designated as delta K513, delta A502, delta Y481, and delta K462, respectively, were expressed in Escherichia coli to define the minimum structure required for transglutaminase activity. delta K513 and delta A502 displayed a 3.8-4.7-fold reduction in the Kcat with no change in the Km for the glutamine substrate and a 2-fold increase in the Km of the primary amine substrate. There was no detectable transglutaminase activity for either thrombin-activated delta Y481 or delta K462. The rate of ammonia release of thrombin- activated delta K513 and delta A502 was reduced 6- and 4-fold, respectively, whereas ammonia release was not detected for the delta Y481 and delta 462 mutants. The Kact for calcium ions of the delta K513 mutant was similar to recombinant FXIIIa, whereas, it was increased by approximately 3-fold for the delta A502 mutant. The rate of fibrin gamma-chain dimer formation for the delta K513 and delta A502 mutants was reduced by approximately 19-fold. delta K462 did not bind to fibrin, while all of the other thrombin-cleaved mutants were bound. In conclusion, these results documented that the carboxyl-terminal calcium binding domain (Asp468-Glu495) was important for FXIIIa to adopt the correct conformation to ensure that efficient catalysis occurred.
Add to CiteULike CiteULike   Add to Complore Complore   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati    What's this?


This article has been cited by other articles:


Home page
FASEB J.Home page
Z. A. HAROON, J. M. HETTASCH, T.-S. LAI, M. W. DEWHIRST, and C. S. GREENBERG
Tissue transglutaminase is expressed, active, and directly involved in rat dermal wound healing and angiogenesis
FASEB J, October 1, 1999; 13(13): 1787 - 1795.
[Abstract] [Full Text]


Home page
J. Biol. Chem.Home page
T.-S. Lai, T. F. Slaughter, K. A. Peoples, and C. S. Greenberg
Site-directed Mutagenesis of the Calcium-binding Site of Blood Coagulation Factor XIIIa
J. Biol. Chem., August 27, 1999; 274(35): 24953 - 24958.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
B. A. Fox, V. C. Yee, L. C. Pedersen, I. Le Trong, P. D. Bishop, R. E. Stenkamp, and D. C. Teller
Identification of the Calcium Binding Site and a Novel Ytterbium Site in Blood Coagulation Factor XIII by X-ray Crystallography
J. Biol. Chem., February 19, 1999; 274(8): 4917 - 4923.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
J. M. Hettasch, K. A. Peoples, and C. S. Greenberg
Analysis of Factor XIII Substrate Specificity Using Recombinant Human Factor XIII and Tissue Transglutaminase Chimeras
J. Biol. Chem., October 3, 1997; 272(40): 25149 - 25156.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
M. Huber, V. C. Yee, N. Burri, E. Vikerfors, A. P. M. Lavrijsen, A. S. Paller, and D. Hohl
Consequences of Seven Novel Mutations on the Expression and Structure of Keratinocyte Transglutaminase
J. Biol. Chem., August 22, 1997; 272(34): 21018 - 21026.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
T.-S. Lai, A. Bielawska, K. A. Peoples, Y. A. Hannun, and C. S. Greenberg
Sphingosylphosphocholine Reduces the Calcium Ion Requirement for Activating Tissue Transglutaminase
J. Biol. Chem., June 27, 1997; 272(26): 16295 - 16300.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
T.-S. Lai, T. F. Slaughter, C. M. Koropchak, Z. A. Haroon, and C. S. Greenberg
C-terminal Deletion of Human Tissue Transglutaminase Enhances Magnesium-dependent GTP/ATPase Activity
J. Biol. Chem., December 6, 1996; 271(49): 31191 - 31195.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 All ASBMB Journals   Molecular and Cellular Proteomics 
 Journal of Lipid Research   ASBMB Today 
Copyright © 1994 by the American Society for Biochemistry and Molecular Biology.